The XylS protein is the positive activator of the TOL plasmid meta-cleavage pathway operon for the metabolism of alkylbenzoates in Pseudomonas putida. The regulator stimulates transcription from the TOL meta pathway operon promoter (Pm) when activated by benzoate effectors or in the absence of effectors when overproduced. xylS mutant alleles that encode regulators which constitutively mediate expression from Pm were isolated and characterized. The mutant proteins all exhibit single amino acid substitutions adjacent to putative a-helix-turn-a-helix domains at their C-terminal ends. The XylS mutant proteins can still be partially activated by the usual and unusual benzoate effectors for the wild-type regulator and when activated stimulate higher levels of transcription from Pm.
Extensive genetic and molecular analyses of procaryotic regulatory systems have identified a number of positive regulators that promote transcription initiation after binding effectors. Examples includes the Escherichia coli araC and malT gene products (14, 18) and the Pseudomonas xylS gene product (16) . The positive regulator is a DNA-binding protein for which target binding sites exist upstream of the RNA polymerase-binding site of the regulated operon. The activation of positive regulators after binding effectors may lead to a conformational change in the regulator and to the conversion of a form inactive in terms of its ability to stimulate transcription to another form able to stimulate transcription from the regulated promoter or of a form with low affinity for its target to one with high affinity.
The TOL plasmid pWWO of Pseudomonas putida specifies enzymes for the oxidative catabolism of toluene and xylenes via benzoate and toluates. Degradation of the aromatic carboxylic acids takes place through a meta-cleavage pathway. Genes encoding the TOL meta-cleavage pathway are grouped into a single operon (see reference 6 for a review) whose expression is positively regulated at the level of transcription by the xylS gene product (4, 7, 17) . Transcription from the meta operon promoter (called Pm for promoter meta pathway [6] or OP2 [7] ) is stimulated by benzoates that are metabolized through the meta pathway or by benzoate analogs that are gratuitous effectors (17) . Transcription from Pm is also stimulated in the absence of benzoate effectors by the hyperproduction of XylS protein (8, 15) . The isolation of XylS mutants with altered effector specificities has provided genetic evidence for the direct binding of benzoate analogs to XylS (16, 17) . In this article, we describe XylS protein mutants that constitutively switch on the meta operon and which contain mutations at their C-terminal ends, adjacent to putative a-helix-turn-a-helix domains likely to be involved in DNA binding.
MATERIALS AND METHODS
Strains, plasmids, and growth media. Escherichia coli 5K (resK thr leu thi tonA supE Xs), E. coli CC118 [araD139 * Corresponding author.
A(ara leu)7697 lacX74 phoA20 galE galK thi rpsE rpoB argE(Am) recAI], and P. putida KT2442 (hsdM hsdR+ Rif) were described before (1).
The following plasmids have been previously described. pWWO is the archetypal TOL plasmid and encodes catabolic pathways for the metabolism of toluene and xylenes and for benzoate and toluates in P. putida (19) . pERD100 is an IncP plasmid that contains a translational fusion of the TOL meta-cleavage pathway operon promoter (Pm) to a promoterless lacZ gene and encodes tetracycline resistance (16) . pKT231 is an IncQ plasmid that encodes resistance to kanamycin and streptomycin (2) . The following plasmids were constructed during this study. pERD103 was constructed by cloning a 1.5-kilobase Sau3A fragment of the TOL plasmid carrying the xylS gene into the unique BamHI site of pKT231 and encodes resistance to kanamycin and streptomycin. Plasmid pJLR200fQ contains a transcriptional fusion of Pm to a promoterless tetracycl.ne gene in pBR322, with the fQ interposon (13) inserted just upstream from Pm to prevent reading of the tet gene from a vector promoter.
Bacteria were grown on LB medium (11) . When required, antibiotics were added at the following concentrations (micrograms per milliliter): ampicillin, 100; kanamycin, 25; rifampin, 50; streptomycin, 50; and tetracycline, 10.
Isolation and sequencing of xylS mutant alleles. xylS alleles encoding mutant regulators that constitutively switch on expression from the TOL meta-cleavage pathway operon promoter (Pm) were isolated as follows. Three milliliters of an E. coli CC118(pERD103) culture containing about 108 cells per ml was harvested (10,000 x g for 2 min), suspended in 1 ml phosphate buffer (100 mM, pH 6.8), and incubated with 30 ,ug of N-methyl-N'-nitro-N-nitrosoguanidine (NTG) for 60 min at 30°C. Cells were then harvested as described above, washed twice with LB medium, and suspended in 3 ml of LB medium (11) . After 24 h, plasmid DNA was isolated and used to transform E. coli(pJLR200Ql). Clones expressing Tcr were directly selected in plates containing 10 ,ug of tetracycline per ml, 25 ,ug of kanamycin per ml, and 100 ,ug of ampicillin per ml. The putative mutations in the xylS gene were cloned in pTZ19 (20) and sequenced by the dideoxy chain termination method, using synthetic oligonucleotides that expanded at intervals of 200 nucleotides within the xylS gene sequence (9) .
Other methods. Isolation of plasmid DNA, restriction endonuclease digestion, cloning, transformation, and matings were performed as previously described (1). 1-Galactosidase was determined in permeabilized cells (17) . Units are expressed as described by Miller (11) .
RESULTS AND DISCUSSION
In our attempts to understand the mechanism of positive regulation of the TOL plasmid meta-cleavage pathway for the metabolism of alkylbenzoates in P. putida, we previously isolated XylS regulator mutants with altered effector specificities (16, 17) ; in the present study we isolated mutants that constitutively mediate transcription from Pm.
To isolate XylS mutants able to mediate constitutive transcription from Pm we used a modification of the strategy previously described to isolate XylS mutants with altered effector specificities (16, 17) . Briefly, E. coli bearing the plasmid pERD103, which carries the xylS wild-type allele, was mutagenized with NTG. After mutagenesis, plasmid DNA was isolated and used to transform E. coli(pJLR200fQ). The latter strain is sensitive to tetracycline because the transcription of the tetracycline-resistant determinant in pJLR200Ql is under the control of the positively regulated Pm promoter. E. coli(pJLR200Q) cells transformed with mutagenized pERD103 were directly spread on LB plates supplemented with ampicillin (the marker for pJLR200fl), kanamycin (the marker for the mutagenized pERD103 plasmid), and tetracycline (to select clones expressing the tetracycline resistance determinant from the Pm promoter in pJLR200fl). A single Apr Kmr Tcr clone from each mutagenesis was randomly chosen. Ten independent clones were maintained for further characterization. The pERD103-derived plasmid was then recovered from the transformant and used again to transform E. coli(pJLR200fQ) to the polypeptide chain. One mutant contained a single T--G change in codon 274 (GAT--GAG), resulting in an Asp-+Glu change. Finally, one mutant contained a single G-*T mutation in codon 229 (AGC--ATC), which should result in a Ser-Ile change. The three mutant types containing changes in the xylS coding sequence were designated mutant Val274, mutant Glu274, and mutant Ile229, respectively. To determine the level of transcription from the Pm promoter mediated by mutant XylS proteins in the presence and absence of benzoate inducers, P-galactosidase levels were measured in E. coli bearing a translational fusion of Pm to the lacZ gene in plasmid pERD100 (16) (16, 17) . Mutant Leu88, although isolated on the basis of its activation by 2,4-dichlorobenzoate, stimulates high basal levels of transcription from Pm, i.e., in the absence of effectors (17) . We suggested that the altered residue of this mutant protein and its surrounding amino acids were involved in signal transmission from the effector-binding pocket to the DNAbinding domain. Moreover, a mutant protein isolated as able to recognize 3-methoxybenzoate (mutant Arg4l) leads to extremely high levels of transcription when hyperproduced, which indicates that residue 41 may also be involved in the transmission of a signal from the effector-binding pocket to the DNA-binding dorpain (16) . These findings suggest that in the XylS protein, reciprocal interactions exist between the effector-binding pocket, the signal transmission region, and DNA-binding domains, since the mutational alterations of one functional domain may affect the functioning of another domain.
Two regions at the C terminus of the XylS protein, homologous to sequences found in other regulators and organized in a-helix-turn-a-helix domains (Fig. 1) , were located by Mermod et al. (9) . One of these domains, consisting of amino acids 233 to 253, is homologous to the a-helix-turn-a-helix domain of the lambda Cro protein and other regulators (12) . In the best alignment of the E. coli AraC and XylS proteins, this region of XylS aligns well with the proposed DNA-binding domain of the AraC protein, which is probably formed by the stretch of amino acids between residues 196 and 215, with residues 208 and 212 apparently contacting regulatory ara DNA sequences (3). The other, less well conserved, domain, comprising amino acids 282 to 302, is found in the XylS family of regulators (Ramos et al., in press), sigma factors, and proteins that interact with DNA, such as the E. coli NusA protein (10) . Interestingly, all three mutations in the XylS regulator which lead to constitutive expression from Pm are located adjacent to but outside these two domains. The substitution of Ile for Ser in mutant Ile229 has only an apparent effect on the local hydrophobicity of the region, but no apparent change in secondary structure was found in analyses performed with 
